CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Serum folate forms are stable during repeated analysis in the presence of ascorbic acid and during frozen sample storage
-
October 12 2018
-
-
Source: J Appl Lab Med. 3(6):993-1002
Details:
-
Alternative Title:J Appl Lab Med
-
Personal Author:
-
Description:Background:
Serum folate forms and particularly tetrahydrofolate are sensitive to oxidation.
Methods:
Using a repeated measures design, we investigated the stability of folate forms in convenience samples with added ascorbic acid (AA, 5 g/L) analyzed initially and after variable (~1–33 weeks) storage time at -70°C. We examined the recovery of tetrahydrofolate added at different spiking levels to serum with and without AA (5 g/L). We also assessed the long-term frozen storage stability of folate forms.
Results:
Repeat analysis produced consistent results with the initial analysis; the mean relative change (95% CI; Lin’s concordance correlation between initial and repeat result; sample size) was 0.08% (-0.24% to 0.39%; rc=0.999; n=301) for 5-methyltetrahydrofolate; 4.23% (2.44% to 6.05%; rc =0.984; n=211) for pyrazino-s-triazine derivative of 4α-hydroxy-5-methyltetrahydrofolate (MeFox); -0.22% (-1.90% to 1.49%; rc =0.986; n=214) for folic acid; and 1.49% (-2.71% to 5.88%; rc =0.889; n=81) for tetrahydrofolate. Linear regression testing for a time trend indicated an estimated average percent change of <±5% for samples retested after 4 months: 5-methyltetrahydrofolate Ptrend=0.0007, folic acid Ptrend <0.0001, MeFox Ptrend =0.38, and tetrahydrofolate Ptrend =0.0256. The mean±SD tetrahydrofolate spiking recovery was 96.7%±9.4% for serum with added AA, but <50% for serum without added AA. We observed ≤10% loss for most serum folate forms during 4 years of storage at -70°C.
Conclusions:
Serum containing added AA showed acceptable stability of folate forms during repeat analysis from the same vial within 4 months, complete spiking recovery of tetrahydrofolate during sample processing, and long-term frozen storage stability of folate forms.
-
Subjects:
-
Source:
-
Pubmed ID:31639690
-
Pubmed Central ID:PMC7263443
-
Document Type:
-
Funding:
-
Volume:3
-
Issue:6
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
[PDF-864.12 KB]
